HOB Biotech Group Corp Ltd (688656) — Cash Flow Reinvestment Rate
HOB Biotech Group Corp Ltd (688656) has a Cash Flow Reinvestment Rate of 0.56x as of December 2025, reinvesting CN¥8.50 Million (capex CN¥8.50 Million ) from operating cash flow of CN¥15.28 Million. See free cash flow generation of HOB Biotech Group Corp Ltd to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
HOB Biotech Group Corp Ltd Cash Flow Reinvestment Rate (2016–2025)
Historical reinvestment intensity for HOB Biotech Group Corp Ltd across 10 annual periods. For the full cash flow conversion analysis, see HOB Biotech Group Corp Ltd cash flow conversion.
Annual Cash Flow Reinvestment Rate for HOB Biotech Group Corp Ltd (2016–2025)
Year-by-year capital reinvestment analysis for HOB Biotech Group Corp Ltd. See 688656 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.01x | CN¥73.90 Million | CN¥72.94 Million | CN¥73.90 Million | ▼ -34.4% |
| 2024 | 1.55x | CN¥156.43 Million | CN¥101.22 Million | CN¥155.37 Million | ▼ -27.1% |
| 2023 | 2.12x | CN¥217.58 Million | CN¥102.69 Million | CN¥178.03 Million | ▼ -78.1% |
| 2022 | 9.67x | CN¥564.07 Million | CN¥58.31 Million | CN¥220.21 Million | ▲ +214.6% |
| 2021 | 3.08x | CN¥322.28 Million | CN¥104.79 Million | CN¥167.89 Million | ▲ +94.5% |
| 2020 | 1.58x | CN¥92.04 Million | CN¥58.22 Million | CN¥57.01 Million | ▲ +58.1% |
| 2019 | 1.00x | CN¥68.55 Million | CN¥68.57 Million | CN¥34.80 Million | ▲ +74.4% |
| 2018 | 0.57x | CN¥26.66 Million | CN¥46.51 Million | CN¥26.66 Million | ▼ -38.7% |
| 2017 | 0.94x | CN¥20.82 Million | CN¥22.26 Million | CN¥20.82 Million | ▼ -65.0% |
| 2016 | 2.67x | CN¥17.15 Million | CN¥6.42 Million | CN¥17.15 Million | — |